Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging
批准号:
10414013
负责人:
Michelle M Mielke
金额:
$40.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2024-05-31
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseAndrostenedioneBilateralBilateral oophorectomyBiologicalBloodBlood VesselsBlood specimenBrainCardiovascular DiseasesCesarean sectionChronicClinicalClinical MarkersCognitionCognitiveCognitive agingDNA MethylationDementiaDoctor of PhilosophyEndocrineEndocrine GlandsEndocrine disruptionEpidemiologyEpigenetic ProcessEquilibriumEstrogensExcisionFunctional disorderFutureGastrointestinal tract structureGoalsHandHand StrengthHealthHeartHormonesHysterectomyLong-Term EffectsLongevityLower ExtremityMalignant NeoplasmsMalignant neoplasm of ovaryMeasuresMediatingMedical Record LinkageMenopauseMuscleNatural experimentOperative Surgical ProceduresOrganOutcomeOvarianOvariectomyOvaryPerformancePersonsPhenotypePhysical FunctionPlasmaPremenopauseProcessProgesteroneProteinsRecording of previous eventsRiskSalpingo-OophorectomySexual DysfunctionSkin AgingSystemTestingTestosteroneTimeTissuesUnited StatesWalkingWomanagedbaseblood-based biomarkerbonecognitive functioncohortdehydroepiandrosteronefrailtyfunctional outcomesindexingmalignant breast neoplasmmortalitymultiple chronic conditionsmuscle strengthnovel markerovarian cancer preventionpopulation basedpreventpreventive interventionprophylacticreceptorrecruitreproductive organsenescencesex
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT 1: SUMMARY/ABSTRACT Michelle M. Mielke, Ph.D.
Hysterectomy is the second most common major surgical procedure performed among women living in the
United States after cesarean section. Among women who undergo hysterectomy, 23% aged 40-44 years and
45% aged 45-49 years undergo bilateral salpingo-oophorectomy (BSO) at the same time to prevent ovarian
cancer. Although premenopausal BSO is associated with a significant reduced risk of ovarian and breast
cancer, there is increasing concern that BSO may have harmful long-term effects which can negate some of
the benefits conferred by protection from cancer. Ovaries are both endocrine and reproductive organs. They
secrete hormones before menopause (primarily estrogen, progesterone, and testosterone) and after (primarily
testosterone, androstenedione, and dehydroepiandrosterone). Thus, reduced ovarian function, especially as
caused by the removal of ovaries, can impact multiple systems throughout the lifespan. Prior to menopause,
ovarian removal causes significant endocrine disruption. The practice of prophylactic BSO is now declining.
However, given the large number of women who have undergone abrupt endocrine disruption by
premenopausal BSO over the past decades, there is an urgent need to understand the impact on long-term
physical and cognitive function. In addition, elucidating the underlying biological mechanisms may help to delay
or prevent the potential negative consequences of premenopausal BSO as these women age. The overall aim
of Project 1 is to better understand the long-term functional and cognitive effects and the potential
underlying mechanisms resulting from abrupt premenopausal endocrine dysfunction. Recent studies
suggest that premenopausal BSO may be associated with accelerated aging. However, the underlying
biological mechanisms have not been examined, other than DNA methylation. In addition, it is not clear
whether the endocrine disruption that results from premenopausal BSO has a global effect on all physical and
cognitive functions, or whether specific domains of physical or cognitive function are more affected than others.
We hypothesize that the abrupt and significant endocrine disruption caused by premenopausal BSO will
contribute to accelerated aging, as measured by a greater decline in physical and cognitive function and by
higher plasma levels of senescence associated secretory phenotype (SASP) proteins compared to referents.
To test these hypotheses, we will utilize an established and well-characterized population-based cohort of
women with and without premenopausal BSO, who are now only passively followed through the Rochester
Epidemiology Project medical-records linkage system. We will recruit, for an in-person study, 250 women with
and 250 women without premenopausal BSO a median of 22 years after their surgery or index date. We will
extensively characterize their physical and cognitive function and collect blood samples to measure SASP
proteins, a novel marker of aging. Studying women who underwent BSO in the past decades provides a unique
natural experiment to understand the effects of endocrine function in regulating the pace of aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African Americans
-
批准号:10441978
-
项目类别:
-
资助金额:$278.88万
-
财政年份:2022
-
负责人:Michelle M Mielke
-
依托单位:
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African Americans
-
批准号:10709216
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2022
-
负责人:Michelle M Mielke
-
依托单位:
Reproductive risk factors for Alzheimer's disease dementia and pathology
-
批准号:9250532
-
项目类别:
-
资助金额:$397.5万
-
财政年份:2017
-
负责人:Michelle M Mielke
-
依托单位:
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's
-
批准号:9265377
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2015
-
负责人:Michelle M Mielke
-
依托单位:
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's
-
批准号:8853439
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2015
-
负责人:Michelle M Mielke
-
依托单位:
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's
-
批准号:9514782
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2015
-
负责人:Michelle M Mielke
-
依托单位:
Leadership Administrative Core
-
批准号:10414011
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2012
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology
-
批准号:8502599
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2011
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology
-
批准号:8325131
-
项目类别:
-
资助金额:$60.36万
-
财政年份:2011
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology
-
批准号:8124975
-
项目类别:
-
资助金额:$51.68万
-
财政年份:2011
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology
-
批准号:8706742
-
项目类别:
-
资助金额:$35.18万
-
财政年份:2011
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology
-
批准号:7945210
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2010
-
负责人:Michelle M Mielke
-
依托单位:
Longitudinal study of membrane lipids: pre-clinical Alzheimer's biomarkers
-
批准号:7659928
-
项目类别:
-
资助金额:$7.38万
-
财政年份:2009
-
负责人:Michelle M Mielke
-
依托单位:
Blood-based lipid biomarkers reflective of Alzheimer-associated neurodegeneration
-
批准号:7329114
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2007
-
负责人:Michelle M Mielke
-
依托单位:
Development of blood lipid biomarkers for Alzheimer's disease progression
-
批准号:7491658
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2007
-
负责人:Michelle M Mielke
-
依托单位:
Blood-based lipid biomarkers reflective of Alzheimer-associated neurodegeneration
-
批准号:7462290
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2007
-
负责人:Michelle M Mielke
-
依托单位:
Development of blood lipid biomarkers for Alzheimer's disease progression
-
批准号:7305882
-
项目类别:
-
资助金额:$17.43万
-
财政年份:2007
-
负责人:Michelle M Mielke
-
依托单位:
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging
-
批准号:9790891
-
项目类别:
-
资助金额:$39.19万
-
财政年份:--
-
负责人:Michelle M Mielke
-
依托单位:
Leadership Administrative Core
-
批准号:9790888
-
项目类别:
-
资助金额:$4.42万
-
财政年份:--
-
负责人:Michelle M Mielke
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: